Producing low-immunogenicity, high-stability mRNA with dsRNA reduction to <0.005% (LLOQ)
Year: 2025
Type: article
Abstract: Optimizing mRNA design for therapeutic applications is critical to ensure maximum protein expression, low impurities and a reduced immune response. This 14-minute video presentation, accompanied by a poster summary, describes how to efficiently generate lower immunogenicity mRNA for downstream applications while also reducing dsRNA using the INCOGNITO™ mScript™ Complete mRNA Production Systems. NEW INTERACTIVE FORMAT Listen to our expert speaker. Watch the video. Read the summary. Focus in on the data. Download the PDF. It has never been easier to quickly access the information you want. All in one place—at the click of a button.
Source: Nucleic Acid Insights
Author: Jen Dennin
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W4417322954
FWCI:
Cites:
Cited by:
Related to: